Synovial Sarcoma News and Research

RSS
FDA grants accelerated approval for first engineered T cell therapy to treat adults with synovial sarcoma

FDA grants accelerated approval for first engineered T cell therapy to treat adults with synovial sarcoma

Routine next-generation sequencing can identify BRAF mutations in synovial sarcoma

Routine next-generation sequencing can identify BRAF mutations in synovial sarcoma

Phase I clinical study of TCR NK cell therapy for sarcoma expected to commence later this year

Phase I clinical study of TCR NK cell therapy for sarcoma expected to commence later this year

Novel T cell receptor therapy shows early promise for treating solid tumors

Novel T cell receptor therapy shows early promise for treating solid tumors

Targeting the Notch pathway with gamma secretase inhibitor improves outcomes in patients with rare cancers

Targeting the Notch pathway with gamma secretase inhibitor improves outcomes in patients with rare cancers

Scientists develop new way to attack synovial sarcoma using an investigational drug

Scientists develop new way to attack synovial sarcoma using an investigational drug

Study generates a picture of the myocardial transcriptional landscape of COVID-19

Study generates a picture of the myocardial transcriptional landscape of COVID-19

New research sheds light on the origins of synovial sarcoma

New research sheds light on the origins of synovial sarcoma

Adaptimmune to report Phase 2 trial data on synovial sarcoma at ASCO congress

Adaptimmune to report Phase 2 trial data on synovial sarcoma at ASCO congress

3D structural model of BAF complex modifies DNA architecture, provides clues on cancer

3D structural model of BAF complex modifies DNA architecture, provides clues on cancer

Adoptive T-cell therapy targeting MAGE-A4 achieves responses in patients with multiple solid tumors

Adoptive T-cell therapy targeting MAGE-A4 achieves responses in patients with multiple solid tumors

Scientists pinpoint protein that plays key role in synovial sarcoma tumors

Scientists pinpoint protein that plays key role in synovial sarcoma tumors

Potential new therapeutic approach developed for synovial sarcoma

Potential new therapeutic approach developed for synovial sarcoma

Scientists receive critical funding to study treatments for three deadly cancers

Scientists receive critical funding to study treatments for three deadly cancers

Early study of experimental vaccine shows escalating immune response in patients with sarcoma

Early study of experimental vaccine shows escalating immune response in patients with sarcoma

Study suggests how existing and emerging immunotherapy treatments could be successful for sarcomas

Study suggests how existing and emerging immunotherapy treatments could be successful for sarcomas

Houston Methodist researcher receives $4 million to create triple negative breast cancer immunotherapy

Houston Methodist researcher receives $4 million to create triple negative breast cancer immunotherapy

Special CD4+ T cells appear to inhibit cancer growth, enhance tumor-killing powers of other immune cells

Special CD4+ T cells appear to inhibit cancer growth, enhance tumor-killing powers of other immune cells

Adaptimmune doses first patient in expanded Phase I/II trial of T-cell therapy for synovial sarcoma

Adaptimmune doses first patient in expanded Phase I/II trial of T-cell therapy for synovial sarcoma

Adaptimmune presents clinical results of NY-ESO TCR therapeutic candidate at ASCO 2015

Adaptimmune presents clinical results of NY-ESO TCR therapeutic candidate at ASCO 2015

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.